ursodeoxycholic acid has been researched along with Atheroma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, SH; Chung, J; Kim, KH; Kwon, K; Lee, SC | 1 |
| An, SH; Chung, J; Kang, SW; Kwon, K | 1 |
| Bode, N; Grebe, A; Kerksiek, A; Latz, E; Lütjohann, D; Nickenig, G; Werner, N; Zimmer, S | 1 |
3 other study(ies) available for ursodeoxycholic acid and Atheroma
| Article | Year |
|---|---|
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow.
Topics: Animals; Apoptosis; Atherosclerosis; Blood Circulation; Carotid Artery, Common; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Monocytes; Plaque, Atherosclerotic; Regulatory Factor X Transcription Factors; Stress, Mechanical; Transcription Factor CHOP; Transcription Factors; Ursodeoxycholic Acid; X-Box Binding Protein 1 | 2015 |
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endoplasmic Reticulum Stress; Human Umbilical Vein Endothelial Cells; Mice; NF-kappa B; Oxidative Stress; Plaque, Atherosclerotic; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Signal Transduction; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
Topics: Animals; Atherosclerosis; Cholagogues and Choleretics; Cholesterol; Crystallization; Dose-Response Relationship, Drug; Mice; Mice, Inbred C57BL; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Plaque, Atherosclerotic; Treatment Outcome; Ursodeoxycholic Acid | 2016 |